Processa Pharmaceuticals, Inc. beat EPS estimates 0% of the time across 1 reported quarters (0 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | — | $-1.19 | — | Miss |
| Q12026 FY2026 | $1.00 | $-1.29 | -229.0% | Miss |
Back to PCSA overview · PCSA holders · PCSA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.